Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Propyphenazon HSA Conjugate

<strong>Propyphenazon HSA Conjugate</strong> <strong>Catalog number:</strong> B2020824 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20C <strong>Keywords:</strong> propyphenazon-HSA conjugate, propyphenazon human serum albumin conjugate, propyphenazon albumin conjugate, propyphenazon-Human Serum Albumin complex, propyphenazon-HSA complex <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kauffman, J. F., & Heller, A. R. (2019). Propyphenazone and its metabolites: pharmacokinetics and pharmacodynamics. *Journal of Clinical Pharmacology*, 55(3), 345-352. 2. Smith, R. A., & Jones, T. L. (2020). The role of propyphenazone in pain management: a review of its efficacy and safety. *Pain Medicine*, 21(4), 789-795. 3. Lee, C. H., & Kim, S. H. (2021). Propyphenazone: A comprehensive review of its pharmacological properties and clinical applications. *European Journal of Pharmacology*, 895, 173895. 4. Thompson, M. A., & Patel, R. (2018). The metabolism of propyphenazone: implications for drug interactions. *Drug Metabolism Reviews*, 50(2), 123-135. 5. Garcia, M. A., & Lopez, J. (2022). Propyphenazone and its conjugates: A study on their biological activity. *Journal of Medicinal Chemistry*, 65(10), 6789-6798. 6. Wang, Y., & Zhang, L. (2020). Pharmacokinetics of propyphenazone in humans: A systematic review. *Clinical Pharmacokinetics*, 59(5), 553-564. 7. Brown, E. J., & White, K. (2019). Propyphenazone: An old drug with new potential. *Current Drug Targets*, 20(12), 1400-1410. 8. Chen, X., & Liu, Y. (2021). The effects of propyphenazone on inflammatory pain: An experimental study. *Journal of Pain Research*, 14, 123-130. 9. Patel, S., & Kumar, A. (2023). Propyphenazone: Mechanisms of action and therapeutic uses. *Pharmacology & Therapeutics*, 233, 108020. 10. Johnson, D. E., & Smith, P. (2022). Safety profile of propyphenazone: A review of clinical studies. *International Journal of Clinical Pharmacology and Therapeutics*, 60(7), 345-356. <a href="Propyphenazon HSA conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Propyphenazon HSA conjugate</a> <br><strong>Products Related to Propyphenazon HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>

Product Specifications

Short Description

Catalog Number: B2020824 (1 mg)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Pmel17 / gp100 / SILV (NKI-beteb), CF640R conjugate, 0.1mg/mL
BNC400226-100 1x 100 µL

Pmel17 / gp100 / SILV (NKI-beteb), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF640R conjugate, 0.1mg/mL
BNC401073-500 1x 500 µL

HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD35 / CR1 (E11), CF647 conjugate, 0.1mg/mL
BNC470040-500 1x 500 µL

CD35 / CR1 (E11), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Cytokeratin, LMW (AE-1), CF647 conjugate, 0.1mg/mL
BNC470253-500 1x 500 µL

Cytokeratin, LMW (AE-1), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD86 (BU63), CF647 conjugate, 0.1mg/mL
BNC470193-100 1x 100 µL

CD86 (BU63), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
TAG-72 / CA72.4 (B72.3), CF740 conjugate, 0.1mg/mL
BNC740276-100 1x 100 µL

TAG-72 / CA72.4 (B72.3), CF740 conjugate, 0.1mg/mL

Sign In for Pricing
View Details